US stocks climb on strong earnings reports and vaccine progress

US stocks climb on strong earnings reports and vaccine progress
Lucas Jackson/Reuters
  • US stocks rose on Wednesday on strong earnings and progress on a COVID-19 vaccine.
  • Nike shares surged, helping to lift the Dow Jones industrial average, after the company smashed revenue and profit expectations.
  • Johnson & Johnson said that it would start its phase-three trial of a COVID-19 vaccine candidate and that it planned to enroll up to 60,000 participants.
  • Watch major indexes update live here.

Stocks rose on Wednesday as a strong earnings report from Nike and progress on a COVID-19 vaccine helped to boost investor sentiment.

Nike surged — pulling the Dow Jones industrial average higher — after it reported better-than-expected earnings and strong growth in its e-commerce business.

Johnson & Johnson said it would begin a phase-three trial of its COVID-19 vaccine candidate. The company plans to enroll up to 60,000 participants in the pivotal trial.

Here's where US indexes stood shortly after the 9:30 a.m. market open on Wednesday:

Read more: Buy these 15 stocks right now before they rally higher, says the Morgan Stanley equity chief who nailed his call for a short-term market meltdown


Tesla traded lower on Wednesday after its Battery Day event on Tuesday failed to delight investors. The company detailed a $25,000 car it expects to begin selling in three years.

Larry Kudlow, an economic adviser to President Donald Trump, said on Tuesday that a V-shaped recovery wasn't dependent on another round of fiscal stimulus.

Read more: A Wall Street expert explains why the market's ongoing turbulence could end within 2 weeks — and pinpoints 3 stocks to grab cheaper now as big investors buy the dip

"I don't think the V-shaped recovery depends on the package, but I do think a targeted package could be a great help," Kudlow said.

Gold fell as much as 1.4%, to $1,873.23 per ounce, losing its strong support level of $1,900. Treasury yields traded mostly flat, while the US dollar gained ground.


Oil prices climbed. West Texas Intermediate crude rose as much as 1.4%, to $40.15 per barrel. Brent crude, oil's international benchmark, jumped 1%, to $42.15 per barrel, at intraday highs.

Read more: Anthony Scaramucci told us his contrarian views on the risks investors face after the elections regardless of who wins — and shared how his $7.5 billion SkyBridge Capital is navigating the market's volatility